Woodline Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Woodline Partners’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.72M	Sell	700,000 -350,000	-33%	-$1.17M	0.01%	820
2025 Q4	$4.18M	Hold	1,050,000	–	–	0.02%	663
2025 Q3	$3.97M	Buy	+1,050,000	New	+$3.56M	0.02%	611

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Woodline Partners's NBP Position: Q1 2026 in Review

Woodline Partners reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 33% in Q1 2026, selling an estimated $1.17M and leaving 700,000 shares worth $1.72M. The position accounts for 0.01% of the portfolio, ranked #820.

Woodline Partners first reported a position in NBP in Q3 2025 and has held it in 3 quarters since. The position peaked at $4.18M in Q4 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Woodline Partners held 700,000 shares of NovaBridge Biosciences American Depositary Shares worth $1.72M as of Q1 2026.
Woodline Partners sold 350,000 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $1.17M.
NovaBridge Biosciences American Depositary Shares made up 0.01% of Woodline Partners's portfolio in Q1 2026, its #820 holding.
Woodline Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2025 and has held it in 3 quarters since.
Woodline Partners's NovaBridge Biosciences American Depositary Shares position peaked at $4.18M in Q4 2025.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.